Breaking News

Tweet TWEET

Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference

Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference

PR Newswire

GREENWOOD VILLAGE, Colo., Jan. 22, 2013

GREENWOOD VILLAGE, Colo., Jan. 22, 2013 /PRNewswire/ -- Ampio Pharmaceuticals,
Inc. (Nasdaq: AMPE) announced today that Mike Macaluso, Chairman and CEO, and
Dr. David Bar-Or, Director and CSO, will present at "NINE"; Noble Financial
Capital Markets' Ninth Annual Equity Conference at the Hard Rock Hotel in
Hollywood, Florida, on Tuesday, January 22 at 12pm Eastern Time.

(LOGO: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

At the time of the presentation, a live audio and high-definition video
webcast of Ampio Pharmaceuticals, Inc. presentation and a copy of the
presentation materials will be available on the Company's web site
www.ampiopharma.com, or through the Noble Financial websites: www.noblefcm.com
or http://www.nobleresearch.com/NINE/home.htm. Ampio Pharmaceuticals, Inc.
recommends registering at least 10 minutes prior to the start of the
presentation to ensure timely access. You will require a Microsoft SilverLight
viewer (a free download from the presentation link) to participate. The
webcast and presentation will also be archived on www.ampiopharma.com for 90
days following the event.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the
rapid development of therapies to treat prevalent inflammatory conditions for
which there are limited treatment options. It aims to provide medicines to
improve the health and quality of life of patients with minimal side effects.
Ampio is developing compounds that decrease inflammation by 1) inhibition of
specific pro-inflammatory compounds by affecting specific pathways at the
protein expression and at the transcription level or 2) activation of a
specific phosphatase or depletion of the available phosphate needed for the
inflammation process. For more information visit: www.ampiopharma.com.

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity
research driven, full-service, investment banking boutique focused on life
sciences, technology and media, emerging growth, companies. The company has
offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In
addition to non-deal road shows and sector-specific conferences throughout the
year, Noble Financial hosts its large format annual equity conference in
January in South Florida featuring 120-150 presenting companies from across
North America and total attendance of close to 600. For more information:
www.noblefcm.com

Forward Looking Statement

Ampio's statements in this press release that are not historical fact and that
relate to future plans or events are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements can be identified by use of words such as
"believe," "expect," "plan," "anticipate," and similar expressions. These
forward-looking statements include risks associated with clinical trials,
expected results, regulatory approvals, successful commercialization and
marketing of Zertane™ and the combination drug in Korea, and changes in
business conditions and similar events. The risks and uncertainties involved
include those detailed from time to time in Ampio's filings with the
Securities and Exchange Commission, including Ampio's Annual Report on Form
10-K and Quarterly Reports on Form 10-Q

Investor Contact:
Rick Giles
Director of Investor Relations
Ampio Pharmaceuticals, Inc.
Direct (720) 437-6530
Email: rgiles@ampiopharma.com

SOURCE Ampio Pharmaceuticals, Inc.

Website: http://www.ampiopharma.com
 
Press spacebar to pause and continue. Press esc to stop.